CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CASP3 | Caspase 3, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CAST | Calpastatin | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CBR1 | Carbonyl reductase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
CBX3 | Chromobox homolog 3 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CCNB1 | Cyclin B1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CCT2 | Chaperonin containing TCP1, subunit 2 (beta) | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CCT3 | Chaperonin containing TCP1, subunit 3 (gamma) | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CCT5 | Chaperonin containing TCP1, subunit 5 (epsilon) | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CCT7 | Chaperonin containing TCP1, subunit 7 (eta) | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CCT8 | Chaperonin containing TCP1, subunit 8 (theta) | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD33 | CD33 molecule | CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Mixed |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD48 | CD48 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD59 | CD59 molecule, complement regulatory protein | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD63 | CD63 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD68 | CD68 molecule | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD82 | CD82 molecule | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD93 | CD93 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD99 | CD99 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CDC42 | Cell division cycle 42 | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
CDC42EP1 | CDC42 effector protein (Rho GTPase binding) 1 | Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CDC7 | Cell division cycle 7 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CDK1 | Cyclin-dependent kinase 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CDK6 | Cyclin-dependent kinase 6 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CDV3 | CDV3 homolog (mouse) | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CELF1 | CUGBP, Elav-like family member 1 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CENPE | Centromere protein E, 312kDa | Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CENPF | Centromere protein F, 350/400kDa | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CEP104 | Centrosomal protein 104kDa | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CFL1 | Cofilin 1 (non-muscle) | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CHD9 | Chromodomain helicase DNA binding protein 9 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CHEK2 | Checkpoint kinase 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CHGA | Chromogranin A (parathyroid secretory protein 1) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CIITA | Class II, major histocompatibility complex, transactivator | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Mixed |
CKB | Creatine kinase, brain | Cancer-related genes Candidate cardiovascular disease genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CLINT1 | Clathrin interactor 1 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CLTA | Clathrin, light chain A | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CLTB | Clathrin, light chain B | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CLTC | Clathrin, heavy chain (Hc) | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CMAS | Cytidine monophosphate N-acetylneuraminic acid synthetase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CNDP1 | Carnosine dipeptidase 1 (metallopeptidase M20 family) | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
CNDP2 | CNDP dipeptidase 2 (metallopeptidase M20 family) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CNN3 | Calponin 3, acidic | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |